Debunking Common Misconceptions About Percutaneous Abdominal Interventions
摘要
Percutaneous image-guided interventions are minimally invasive alternatives to surgery for diagnosis and management of various abdominal disease processes. However, persistent misconceptions about these procedures continue to hinder their appropriate use. This review addresses common myths that can lead to unnecessary treatment delays or use of more invasive interventions, including concerns about the safety of splenic biopsy, rigid contraindications for antiplatelet medication use, bleeding risks with direct liver mass puncture, tumor seeding from renal biopsies, complications from multiple liver biopsy passes, and increased risk of liver biopsy in the setting of ascites. By clarifying these issues, this article aims to promote evidence-based use of percutaneous procedures.